☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
SetPoint Medical
SetPoint Medical’s Neuroimmune Modulation Platform Obtains the US FDA’s Breakthrough Device Designation to Treat Multiple Sclerosi...
March 14, 2024
Load more...
Back to Home